Growth Metrics

Edwards Lifesciences (EW) Finished Goods (2016 - 2025)

Edwards Lifesciences has reported Finished Goods over the past 12 years, most recently at $676.7 million for Q4 2025.

  • Quarterly results put Finished Goods at $676.7 million for Q4 2025, up 11.04% from a year ago — trailing twelve months through Dec 2025 was $676.7 million (up 11.04% YoY), and the annual figure for FY2025 was $676.7 million, up 11.04%.
  • Finished Goods for Q4 2025 was $676.7 million at Edwards Lifesciences, up from $642.2 million in the prior quarter.
  • Over the last five years, Finished Goods for EW hit a ceiling of $676.7 million in Q4 2025 and a floor of $511.4 million in Q4 2023.
  • Median Finished Goods over the past 3 years was $611.0 million (2024), compared with a mean of $610.9 million.
  • Biggest five-year swings in Finished Goods: increased 19.16% in 2024 and later decreased 11.1% in 2025.
  • Edwards Lifesciences' Finished Goods stood at $511.4 million in 2023, then increased by 19.16% to $609.4 million in 2024, then increased by 11.04% to $676.7 million in 2025.
  • The last three reported values for Finished Goods were $676.7 million (Q4 2025), $642.2 million (Q3 2025), and $630.5 million (Q2 2025) per Business Quant data.